The first biological choice in patients with rheumatoid arthritis: data from the Moroccan register of biotherapies.
Meryem Eddaoudi(Hôpital El Ayachi), R. Bahiri(Centre Hospitalier Universitaire de Rabat-Salé), L. Achemlal, I. Ghozlani(Régie Autonome Multi Services D'Agadir), Bouchra Amine(Hôpital El Ayachi), H. Hassikou, F. Allali(Délégation Paris 5), I. El Binoune(Centre Hospitalier Ibn Sina), I. El Bouchti, Taoufik Harzy(Hôpital El Ayachi), Rédouane Abouqal(Mohammed V University), Ihsane Hmamouchi(International University of Rabat), S. Rostom(Mohammed V University), Ouafae Mkinsi(Centre Hospitalier Universitaire Ibn Rochd), A. El Maghraoui, Redouane Niamane(Hôpital Militaire Avicenne), L. Ichchou(Hôpital El Ayachi)
Cited by 6
Related Papers
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review
|Seminars in Arthritis and Rheumatism|2018|164
High Prevalence of Hypovitaminosis D in Morocco: Relationship to Lifestyle, Physical Performance, Bone Markers, and Bone Mineral Density
|Seminars in Arthritis and Rheumatism|2008|154
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α
|Annals of the Rheumatic Diseases|2003|122
Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors
|Rheumatology International|2017|114